«IL - 28B is a key regulator of B - and T - Cell vaccine
responses against influenza» by Adrian Egli et al. published in PLOS Pathogens on Thursday 11 December 2014.
Vaclac Vetvicka, Jana Vetvickova, «Glucan supplementation enhances the immune
response against an influenza challenge in mice,» Ann Transl Med, 2015 Feb; 3 (2): 22.
Not exact matches
A team led by Ron Dagan, a pediatric infectious disease specialist at Soroka University Medical Center in Beer - Sheva, Israel, wanted to know if a new pneumococcal vaccine based on tetanus toxoid would change infants» immune
responses to the standard regimen of vaccines, including those for diphtheria, tetanus, pertussis (DTP), and Haemophilus
influenzae type B, which protects
against meningitis.
Back to the future: Immunization with M - 001 prior to trivalent
influenza vaccine in 2011/12 enhanced protective immune
responses against 2014/15 epidemic strain.
Researchers concluded that the high - dose vaccine is safe, induces significantly higher antibody
responses, and provides superior protection
against laboratory - confirmed
influenza illness compared to standard dose among persons over 65 years of age.
«Our findings suggest that different prostaglandins have different roles in antiviral immunity and that specific inhibition of PGE2 will be an effective therapy
against influenza viral infection by boosting immune
responses.»
On the basis of the current studies as well as previous reports on the use of intradermal immunization
against influenza, hepatitis B, rabies, and other infectious diseases, 2,3,8 it is becoming clear that use of the intradermal route may at least partially overcome the relatively poor
influenza - specific immune
responses seen in certain at - risk populations, particularly the elderly, in whom the immune
response in general is known to diminish with age.9 Moreover, in times of shortage, the dose - sparing intradermal approach might be particularly well suited to the young, healthy persons included in the CDC's high - priority group for vaccination, such as health care workers, as well as to younger, otherwise healthy populations in general.
Broadly cross-reactive antibodies dominate the human B cell
response against 2009 pandemic H1N1
influenza virus infection
Live attenuated
influenza vaccines have been shown to provide better immune
responses to protect
against influenza.
FLORHAM PARK, N.J., Sept. 9, 2014 — Zoetis has partnered with the renowned Gluck Equine Research Center at the University of Kentucky to show that FLUVAC INNOVATOR ®, the first equine
influenza virus (EIV) vaccine, can provide a demonstrated cross-reactive immune
response against emerging EIV strains.
In
response to a canine
influenza outbreak at a local pet boarding facility, Central Veterinary Associates is urging all pet owners to have their pets vaccinated
against the canine flu, if they have not already done so, prior to having their pets boarded.
Evaluation of the ability of canarypox - vectored equine
influenza virus vaccines to induce humoral immune
responses against canine
influenza viruses in dogs.
Responses indicate that facilities are increasingly aware of Dog Flu (also known as canine
influenza) and are taking steps
against it.1
The Type A
influenza virus has on its surface an assortment of proteins which determine its «strain» or subtype, and it is
against these surface proteins that our bodies mount an immune
response.